Issuance of Priority Review Voucher; Rare Pediatric Disease Product; WASKYRA (etuvetidigene autotemcel) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-0672

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; WASKYRA (etuvetidigene autotemcel)

Documents

Comments

Description

OPEN

Type	Title	Posted	Comments	Status
Notice	Issuance of Priority Review Voucher; Rare Pediatric Disease Product; WASKYRA (etuvetidigene autotemcel) FR Doc: 2026-03493	Feb 23, 2026	--	--

CBER

2025-665

Notice

Issuance of Priority Review Voucher

Rare Pediatric Disease Product; WASKYRA

(etuvetidigene autotemcel)

OPEN